Cereno Scientific is a clinical stage biotech company within cardiovascular diseases. The lead drug candidate, CS1, is a Phase II candidate in development for the treatment of the rare disease pulmonary arterial hypertension (PAH) and thrombotic indications. CS1 is an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties, all relevant for PAH. In addition, Cereno has two promising preclinical development programs named CS014 and CS585 targeted at treating cardiovascular diseases. The company is headquartered in AstraZeneca's BioVenture Hub, Sweden, and has a US subsidiary Cereno Scientific Inc. based in Kendall Square in Boston, Massachusetts, US. Cereno is listed on the Swedish Spotlight Stock Market (CRNO B).
View Top Employees from Cereno Scientific AB| Website | http://www.cerenoscientific.com |
| Revenue | $7 million |
| Employees | 1 (1 on RocketReach) |
| Address | 1 Pepparedsleden, Moelndal, Vaestra Goetaland, SE |
| Phone | +46 76 866 77 87 |
| Industry | Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies |
Looking for a particular Cereno Scientific AB employee's phone or email?
Cereno Scientific AB Questions
The Cereno Scientific AB annual revenue was $7 million in 2024.
Jan-Peter Idström is the Senior Director of Cereno Scientific AB.
1 people are employed at Cereno Scientific AB.
Cereno Scientific AB is based in Moelndal, Vaestra Goetaland.
The NAICS codes for Cereno Scientific AB are [54, 541713, 54171, 5417, 541].
The SIC codes for Cereno Scientific AB are [873, 87].
Top Cereno Scientific AB Employees
